Financial Advocates Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $566K | Sell |
2,193
-379
| -15% | -$97.8K | 0.05% | 332 |
|
2025
Q1 | $576K | Buy |
2,572
+36
| +1% | +$8.06K | 0.04% | 395 |
|
2024
Q4 | $580K | Sell |
2,536
-115
| -4% | -$26.3K | 0.03% | 412 |
|
2024
Q3 | $647K | Sell |
2,651
-157
| -6% | -$38.3K | 0.04% | 398 |
|
2024
Q2 | $537K | Buy |
2,808
+513
| +22% | +$98.2K | 0.03% | 419 |
|
2024
Q1 | $455K | Buy |
2,295
+23
| +1% | +$4.56K | 0.03% | 473 |
|
2023
Q4 | $391K | Buy |
+2,272
| New | +$391K | 0.03% | 477 |
|
2023
Q3 | – | Sell |
-1,255
| Closed | -$274K | – | 727 |
|
2023
Q2 | $274K | Sell |
1,255
-2
| -0.2% | -$437 | 0.02% | 544 |
|
2023
Q1 | $275K | Sell |
1,257
-529
| -30% | -$116K | 0.02% | 575 |
|
2022
Q4 | $372K | Buy |
+1,786
| New | +$372K | 0.03% | 505 |
|
2022
Q3 | – | Sell |
-5,046
| Closed | -$1.06M | – | 814 |
|
2022
Q2 | $1.06M | Buy |
5,046
+2,033
| +67% | +$426K | 0.09% | 257 |
|
2022
Q1 | $731K | Sell |
3,013
-145
| -5% | -$35.2K | 0.05% | 363 |
|
2021
Q4 | $823K | Sell |
3,158
-35
| -1% | -$9.12K | 0.05% | 362 |
|
2021
Q3 | $842K | Buy |
3,193
+721
| +29% | +$190K | 0.06% | 352 |
|
2021
Q2 | $606K | Sell |
2,472
-348
| -12% | -$85.3K | 0.04% | 429 |
|
2021
Q1 | $547K | Buy |
+2,820
| New | +$547K | 0.04% | 448 |
|